Biotech Fluidics' range of degassing systems includes open-framed degasser modules
Targeting the developmental state of cancer cells could provide a successful avenue for treatment
The assay uses genetic insights to identify patients with dihydropyrimidine dehydrogenase deficiency
The solution is designed to supercharge AI-driven high-throughput screening pipelines for antibody drug discovery
AndzonBio2, the ALBORADA Drug Discovery Institute at the University of Cambridge and Cambridge Enterprise are collaborating
Sign in to your account